No Prescription |
 |
 | ||
|
Chlorsig Eye Drops Generic Chloramphenicol |
|
| ||
No Prescription » Prescription Drugs 4 » Chlorsig Eye Drops Generic Chloramphenicol Indications:For the treatment of bacterial conjunctivitis and other superficial ocular infections caused by chloramphenicol-sensitive organisms.This medication is used to treat bacterial eye infections. Chloramphenicol is an antibiotic that works by stopping the growth of bacteria.This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.Dosage and Administration:CHLORSIG EYE DROPS: Instil 1 or 2 drops in the affected eye(s) every two to six hours for two to three days. The interval between applications may then be increased. Discard solution within one month of opening container. Buy Chlorsig Eye Drops Generic Chloramphenicol and other Prescription Drugs 4 products online at Medstore. Buy Online at Medstore - Click Here!
About Chlorsig Eye Drops Generic Chloramphenicol: Product Type: Prescription Drugs 4 Chlorsig Eye Drops( Generic Chloramphenicol ) Chlorsig Eye Drops (Generic Chloramphenicol) Generic Chloramphenicol 0.5%w/v 30mL(3 x 10mL) 10mL Generic Chloramphenicol Chlorsig Eye Drops
View more Prescription Drugs 4 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
